• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login/ Register
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Validation of the predictive role of A.muciniphila for response and resistance to PD1 blockade in non small cell lung cancers

April 15, 2022 Laurence Zitvogel Editor's Choice, Pharma & Human Health

 

Laurence Zitvogel
Group Leader of Tumour immunology and immunotherapy of cancer at Institut Gustave Roussy

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • FDA Approves First Fecal Microbiota Product
    December 1, 2022
  • Seres Therapeutics Announces FDA acceptance of Biologics License Application For Ser-109
    October 28, 2022
  • A microbiome therapeutic is closer than ever to market authorization in the US. What does it mean for the industry?
    September 28, 2022
  • Ferring Receives Positive Vote from U.S. FDA Advisory Committee for RBX2660
    September 23, 2022
  • Stanford researchers construct most complex, complete synthetic microbiome
    September 9, 2022
sign up

Sign up to the Microbiome Times newsletterÂ